Should our risk predictions and calculus for choosing a pharmacotherapeutic or more invasive intervention also change?
Predictions of risk guide our clinical decisions about which interventions to adopt and thus need to be informed by the most contemporary information. As medicine evolves quickly, our assumptions about risk need to be updated constantly.
The risk for sudden death in patients with heart failure is particularly important. To mitigate this risk, clinicians commonly have used devices like implantable cardioverter-defibrillators (ICDs), at considerable cost and some hazard. As more patients are treated with evidence-based medications, however, we have little way to track whether the risk is changing. To address this issue, investigators combined information from 12 randomized, controlled, clinical trials conducted from 1995 through 2014. They exc…
Reviewing Author
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association